Exciting News! Saama Wins “AI-based Life Sciences Solution of the Year” Award in 2026 AI Breakthrough Awards

Our Investors

Saama’s investors include several healthcare-focused venture funds from top pharmaceutical companies, who collectively believe in our vision of accelerating clinical trials through AI.

Source to Submission (S2S)

Our Investors Include:

Carlyle
Merck
Pfizer
Amgen
Mckesson
Intermountain Ventures
Northpond Ventures
Population Health Partners